If you haven’t seen it yet, this data visualization from Nathaniel Lash and Aubrey Whelan at the Philadelphia Inquirer breaks down what happened to OxyContin 80mg sales after the reformulation in 2010, including the shift to 30mg Roxicodone. It’s a fairly compelling, albeit circumstantial, story that some of the biggest pharmacy orders were likely going for diversion. We’ve seen the same pattern all over the country.
Hat tip to Apostolos for bringing it to our attention.